Pinnacle Associates’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
|
|||||
2018
Q3 | $249K | Sell |
|
|||||
2018
Q2 | $203K | Sell |
|
|||||
2018
Q1 | $135K | Sell |
|
|||||
2017
Q4 | $70K | Sell |
|
|||||
2017
Q3 | $46K | Sell |
|
|||||
2017
Q2 | $1.17M | Sell |
|
|||||
2017
Q1 | $2.07M | Sell |
|
|||||
2016
Q4 | $2.1M | Sell |
|
|||||
2016
Q3 | $2.69M | Sell |
|
|||||
2016
Q2 | $2.85M | Sell |
|
|||||
2016
Q1 | $2.78M | Buy |
|
|||||
2015
Q4 | $3.43M | Sell |
|
|||||
2015
Q3 | $4.37M | Sell |
|
|||||
2015
Q2 | $5M | Sell |
|
|||||
2015
Q1 | $6.24M | Buy |
|
|||||
2014
Q4 | $6.23M | Buy |
|
|||||
2014
Q3 | $5.82M | Sell |
|
|||||
2014
Q2 | $6.51M | Sell |
|
|||||
2014
Q1 | $24.7M | Sell |
|
|||||
2013
Q4 | $11.3M | Sell |
|
|||||
2013
Q3 | $14.5M | Buy |
|
|||||
2013
Q2 | $6.15M | Buy |
|